Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience

Omalizumab therapy is effective and safe in patients with chronic spontaneous urticaria (CSU) resistant to nonsedating histamine1 (H1) antihistamines (nsAHs).

http://ift.tt/2I64MY5